Cardiovascular Research In - DC District of Columbia, Washington 20010

Cardiovascular Research In entered the industry of Cardiologists in 2009 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 621111, which describes it as a Cardiologists. For further clarification, the SIC classifies this business under the code 8011 and described it as a Cardiologists. The business provides service to the B2C market.

To acquire more information, please contact Mikki Ashin by calling (202) 877-7949 during business hours. You can also write to the business’ Single Location at 110 Irving St Nw # 6d, Washington, District of Columbia DC 20010. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Cardiovascular Research In
Representative: Mikki Ashin
Place of Business: 110 Irving St Nw # 6d, Washington, DC 20010
Contact Number: (202) 877-7949
Type of Service: Cardiologists
SIC Number: 8011
NAICS Number: 621111
Locality: Single Location
Market Type: B2C (Business to Consumer)
Began: 2009
Income/Year: $100.000 to $499.999
Laborers: 1 to 4
Share This Company:

Cardiovascular Research In is a company operating from District of Columbia, District of Columbia providing professional Cardiologists and relevant B2C variables. It was founded in 2009 and registered with the SIC code 8011 as Cardiologists, and with the NAICS code 621111 as Cardiologists.

With a current employee count of 1 to 4, Cardiovascular Research In has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Mikki Ashin at (202) 877-7949 for related queries, or to locate its Single Location using the coordinates 38.931035,-77.014044.

The Single Location can also be found at the street address 110 Irving St Nw # 6d in Washington, District of Columbia 20010 and can be engaged online through the company website at , the company Twitter , and Facebook page .